IMPACT OF OZANIMOD (OZA) ON INTERLEUKIN-17A (IL-17A) LEVELS AND THE ASSOCIATION WITH OZA EFFICACY IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (UC): RESULTS FROM THE PHASE 3 TRUE NORTH (TN) STUDY

Sarah Harris ¹ Rachel Maddux ¹ Chun Wu ¹ Yanhua Hu ¹ AnnKatrin Petersen ¹ Severine Vermeire ²
¹ Bristol Myers Squibb, Princeton, United States
² University of Leuven, Leuven, Belgium

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing